These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 25188375)

  • 61. The identifiable virtual patient model: comparison of simulation and clinical closed-loop study results.
    Kanderian SS; Weinzimer SA; Steil GM
    J Diabetes Sci Technol; 2012 Mar; 6(2):371-9. PubMed ID: 22538149
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A closed-loop artificial pancreas using model predictive control and a sliding meal size estimator.
    Lee H; Buckingham BA; Wilson DM; Bequette BW
    J Diabetes Sci Technol; 2009 Sep; 3(5):1082-90. PubMed ID: 20144421
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
    Bode BW; Johnson JA; Hyveled L; Tamer SC; Demissie M
    Diabetes Technol Ther; 2017 Jan; 19(1):25-33. PubMed ID: 28055230
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Novel insulin delivery profiles for mixed meals for sensor-augmented pump and closed-loop artificial pancreas therapy for type 1 diabetes mellitus.
    Srinivasan A; Lee JB; Dassau E; Doyle FJ
    J Diabetes Sci Technol; 2014 Sep; 8(5):957-68. PubMed ID: 25049364
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, Canada.
    Cohen E; Tsoukas MA; Legault L; Vallis M; Von Oettingen JE; Palisaitis E; Odabassian M; Yale JF; Garfield N; Gouchie-Provencher N; Rutkowski J; Jafar A; Ghanbari M; Haidar A
    Lancet Digit Health; 2024 Jul; 6(7):e489-e499. PubMed ID: 38906614
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Unannounced Meal Challenges Using an Advanced Hybrid Closed-Loop System.
    Shalit R; Minsky N; Laron-Hirsh M; Cohen O; Kurtz N; Roy A; Grosman B; Benedetti A; Tirosh A
    Diabetes Technol Ther; 2023 Sep; 25(9):579-588. PubMed ID: 37335759
    [No Abstract]   [Full Text] [Related]  

  • 67. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.
    Kropff J; Del Favero S; Place J; Toffanin C; Visentin R; Monaro M; Messori M; Di Palma F; Lanzola G; Farret A; Boscari F; Galasso S; Magni P; Avogaro A; Keith-Hynes P; Kovatchev BP; Bruttomesso D; Cobelli C; DeVries JH; Renard E; Magni L;
    Lancet Diabetes Endocrinol; 2015 Dec; 3(12):939-47. PubMed ID: 26432775
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Safety of closed-loop therapy during reduction or omission of meal boluses in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Maltoni G; Allen JM; Nodale M; Kumareswaran K; Leelarathna L; Thabit H; Caldwell K; Wilinska ME; Calhoun P; Kollman C; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2014 Nov; 16(11):1174-8. PubMed ID: 24909206
    [TBL] [Abstract][Full Text] [Related]  

  • 69. First Outpatient Clinical Trial of a Full Closed-Loop Artificial Pancreas System in South America.
    Garelli F; Fushimi E; Rosales N; Arambarri D; Mendoza L; Serafini MC; Moscoso-Vásquez M; Stasi M; Duette P; García-Arabehety J; Giunta JN; De Battista H; Sánchez-Peña R; Grosembacher L
    J Diabetes Sci Technol; 2023 Jul; 17(4):1008-1015. PubMed ID: 35549733
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Postprandial glycemic excursions with the use of a closed-loop platform in subjects with type 1 diabetes: a pilot study.
    van Bon AC; Hermanides J; Koops R; Hoekstra JB; DeVries JH
    J Diabetes Sci Technol; 2010 Jul; 4(4):923-8. PubMed ID: 20663458
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System.
    Messer LH; Forlenza GP; Sherr JL; Wadwa RP; Buckingham BA; Weinzimer SA; Maahs DM; Slover RH
    Diabetes Care; 2018 Apr; 41(4):789-796. PubMed ID: 29444895
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Timing of bolus in children with type 1 diabetes using continuous subcutaneous insulin infusion (TiBoDi Study).
    Scaramuzza AE; Iafusco D; Santoro L; Bosetti A; De Palma A; Spiri D; Mameli C; Zuccotti GV
    Diabetes Technol Ther; 2010 Feb; 12(2):149-52. PubMed ID: 20105045
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A single-blind, randomised, crossover study to reduce hypoglycaemia risk during postprandial exercise with closed-loop insulin delivery in adults with type 1 diabetes: announced (with or without bolus reduction) vs unannounced exercise strategies.
    Tagougui S; Taleb N; Legault L; Suppère C; Messier V; Boukabous I; Shohoudi A; Ladouceur M; Rabasa-Lhoret R
    Diabetologia; 2020 Nov; 63(11):2282-2291. PubMed ID: 32740723
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A Deep Learning Framework for Automatic Meal Detection and Estimation in Artificial Pancreas Systems.
    Daniels J; Herrero P; Georgiou P
    Sensors (Basel); 2022 Jan; 22(2):. PubMed ID: 35062427
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Contribution of the dawn phenomenon to the fasting and postbreakfast hyperglycemia in type 1 diabetes treated with once-nightly insulin glargine.
    King AB; Clark D; Wolfe GS
    Endocr Pract; 2012; 18(4):558-62. PubMed ID: 22548951
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Optimized Mealtime Insulin Dosing for Fat and Protein in Type 1 Diabetes: Application of a Model-Based Approach to Derive Insulin Doses for Open-Loop Diabetes Management.
    Bell KJ; Toschi E; Steil GM; Wolpert HA
    Diabetes Care; 2016 Sep; 39(9):1631-4. PubMed ID: 27388474
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Role of Protein and Fat Intake on Insulin Therapy in Glycaemic Control of Paediatric Type 1 Diabetes: A Systematic Review and Research Gaps.
    Furthner D; Lukas A; Schneider AM; Mörwald K; Maruszczak K; Gombos P; Gomahr J; Steigleder-Schweiger C; Weghuber D; Pixner T
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684559
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Stress Testing of an Artificial Pancreas System With Pizza and Exercise Leads to Improvements in the System's Fuzzy Logic Controller.
    Mauseth R; Lord SM; Hirsch IB; Kircher RC; Matheson DP; Greenbaum CJ
    J Diabetes Sci Technol; 2015 Sep; 9(6):1253-9. PubMed ID: 26370244
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide.
    Sherr JL; Patel NS; Michaud CI; Palau-Collazo MM; Van Name MA; Tamborlane WV; Cengiz E; Carria LR; Tichy EM; Weinzimer SA
    Diabetes Care; 2016 Jul; 39(7):1127-34. PubMed ID: 27208332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.